Nosopharm
PrivateLast Round
Debt
Feb 12, 2018
Total Funding Raised
$1.2M
Company Overview
Nosopharm is a biotechnology company that specializes in the research and development of new anti-infective drugs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nosopharm Comparables
Compare Nosopharm with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VenatoRx Pharmaceuticals | 76% | |
| Bioversys | 76% | |
| Spero Therapeutics, Inc. | 75% | |
Nosopharm Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Feb 12, 2018 | ||||
| VC Round | Mar 28, 2017 |
Nosopharm Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alto Invest | VC Round |
| Kreaxi | VC Round |
| Région Occitanie | Grant |
| Auriga Partners | VC Round |
| Bpifrance | Grant, Debt |
| Direction générale de l'armement (DGA) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 12, 2018
$1.2M round led by Bpifrance
- Mar 28, 2017
Raised $2.6M from Alto Invest, Auriga Partners, and Kreaxi.
Nosopharm Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nosopharm's valuation, stock price, and market status.